Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OS
3476
DELISTED
OneStream Inc
OS
| $487K | ﹤0.01% |
22,831
+521
| +2% | +$13.4K |
|
3477
Amylyx Pharmaceuticals
AMLX
$2.5B
| $486K | ﹤0.01% |
137,405
+62,560
| +84% | +$223K |
|
3478
Bit Digital
BTBT
$520M
| $485K | ﹤0.01% |
240,156
-47,161
| -16% | -$136K |
|
3479
Ironwood Pharmaceuticals
IRWD
$674M
| $484K | ﹤0.01% |
329,389
-39,887
| -11% | -$95K |
|
|
TRML
3480
DELISTED
Tourmaline Bio
TRML
| $484K | ﹤0.01% |
31,795
-26,771
| -46% | -$429K |
|
3481
Vaalco Energy
EGY
$592M
| $483K | ﹤0.01% |
128,559
-50,829
| -28% | -$212K |
|
|
NLOP
3482
Net Lease Office Properties
NLOP
$173M
| $483K | ﹤0.01% |
15,391
-7,389
| -32% | -$232K |
|
3483
CALL
Kaspi.kz JSC
KSPI
$18.9B
| $483K | ﹤0.01% |
+5,200
| New | +$510K |
|
|
ITIC
3484
Investors Title Co
ITIC
$534M
| $481K | ﹤0.01% |
1,997
-556
| -22% | -$129K |
|
|
API
3485
Agora
API
$408M
| $480K | ﹤0.01% |
119,486
-86
| -0.1% | -$449 |
|
3486
Mitek Systems
MITK
$853M
| $478K | ﹤0.01% |
57,980
-24,162
| -29% | -$235K |
|
|
SAGE
3487
DELISTED
Sage Therapeutics
SAGE
| $474K | ﹤0.01% |
59,587
-35,861
| -38% | -$263K |
|
|
LINE
3488
Lineage Inc
LINE
$9.8B
| $472K | ﹤0.01% |
8,056
+3,186
| +65% | +$186K |
|
|
PKST
3489
DELISTED
Peakstone Realty Trust
PKST
| $471K | ﹤0.01% |
37,364
-25,238
| -40% | -$286K |
|
|
EHAB
3490
DELISTED
Enhabit
EHAB
| $471K | ﹤0.01% |
53,542
-25,640
| -32% | -$215K |
|
3491
Jakks Pacific
JAKK
$294M
| $470K | ﹤0.01% |
19,063
-3,680
| -16% | -$104K |
|
3492
Real Brokerage
REAX
$523M
| $470K | ﹤0.01% |
115,745
-50,019
| -30% | -$237K |
|
3493
Under Armour Class C
UA
$2.25B
| $469K | ﹤0.01% |
78,862
-262,360
| -77% | -$1.79M |
|
3494
BigBear.ai
BBAI
$1.6B
| $467K | ﹤0.01% |
163,299
+1,842
| +1% | +$8.77K |
|
3495
Invesco DB Agriculture Fund
DBA
$1.23B
| $466K | ﹤0.01% |
17,700
-47
| -0.3% | -$1.27K |
|
3496
Theravance Biopharma
TBPH
$878M
| $465K | ﹤0.01% |
52,033
-22,757
| -30% | -$212K |
|
3497
Clarivate
CLVT
$1.25B
| $464K | ﹤0.01% |
118,131
+26,716
| +29% | +$127K |
|
|
SFIX
3498
Stitch Fix
SFIX
$487M
| $464K | ﹤0.01% |
142,794
-34,374
| -19% | -$157K |
|
3499
Schneider National
SNDR
$6.37B
| $464K | ﹤0.01% |
20,308
-24,686
| -55% | -$669K |
|
3500
Security National Financial
SNFCA
$241M
| $463K | ﹤0.01% |
42,201
-6,178
| -13% | -$70.1K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.